ijerph-logo

Journal Browser

Journal Browser

2nd Edition: Drug Utilisation Studies in Paediatrics

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Children's Health".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 1454

Special Issue Editor


E-Mail Website
Guest Editor
Division of Medical Sciences and Graduate Entry Medicine, University of Nottingham, Derby DE22 3DT, UK
Interests: drug toxicity; clinical trials; rational use of medicines; epidemiology of the use of medicines; inequalities in child health; access to medicines in children
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Drug therapy in children is essential to reduce mortality and morbidity. Unfortunately, many medicines are used inappropriately, which may result in toxicity or drug resistance. The study of the utilisation of medicines in paediatric patients is linked to the need for more rational prescribing.

This Special Issue welcomes papers from any paediatric setting that describes the use of medicines in any paediatric age group. It is not focused on either off-label or unlicensed drug use.

We welcome studies:

  • Looking at either one group of medicines or all medicines.
  • Addressing drug utilisation in any paediatric age group.
  • Addressing drug utilisation in primary, secondary or tertiary care.
  • Evaluating whether medicines are used rationally.
  • Evaluating practice in relation to guidelines regarding the use of medicines.
  • From all countries, as different medicines are needed in different parts of the world.

Original research articles and reviews are welcome.

You may choose our Joint Special Issue in Children.

Prof. Dr. Imti Choonara
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug utilization
  • pharmacoepidemiology
  • antiepileptic drug
  • antibiotic
  • analgesic
  • paediatric
  • neonatal
  • antiasthmatic drugs
  • rational drug use
  • prescribing patterns

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 310 KiB  
Article
Treatment Harms in Paediatric Primary Care
by David M. Reith, Sharon Leitch, Kyle Eggleton, Katharine Wallis, Steven Lillis, Martyn Williamson and Wayne Cunningham
Int. J. Environ. Res. Public Health 2023, 20(14), 6378; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph20146378 - 17 Jul 2023
Viewed by 879
Abstract
The aim of this study was to describe the epidemiology in children of harms detectable from general practice records, and to identify risk factors. The SHARP study examined 9076 patient records from 44 general practices in New Zealand, with an enrolled population of [...] Read more.
The aim of this study was to describe the epidemiology in children of harms detectable from general practice records, and to identify risk factors. The SHARP study examined 9076 patient records from 44 general practices in New Zealand, with an enrolled population of 210,559 patients. “Harm” was defined as disease, injury, disability, suffering, and death, arising from the health system. The age group studied was ≤20 years of age. There were 193 harms to 141 children and adolescents during the 3-year study period. Harms were reported in one (3.5%) patient aged <2 years, 80 (6.6%) aged 2 to <12 years, 36 (4.9%) aged 12 to <18 years, and 24 (7.5%) aged 18 to ≤20 years. The annualised rates of harm were 36/1000 child and adolescent population for all harms, 20/1000 for medication-related harm (MRH), 2/1000 for severe MRH, and 0.4/1000 for hospitalisation. For MRH, the drug groups most frequently involved were anti-infectives (51.9%), genitourinary (15.4%), dermatologicals (12.5%), and the nervous system (9.6%). Treatment-related harm in children was less common than in a corresponding adult population. MRH was the most common type of harm and was related to the most common treatments used. The risk of harm increased with the number of consultations. Full article
(This article belongs to the Special Issue 2nd Edition: Drug Utilisation Studies in Paediatrics)
Back to TopTop